Cabot-Wellington’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,832
| Closed | -$253K | – | 8 |
|
|
2022
Q2 | $253K | Sell |
4,832
-3,664
| -43% | -$187K | 0.16% | 8 |
|
|
2022
Q1 | $378K | Hold |
8,496
| – | – | 0.19% | 9 |
|
|
2021
Q4 | $502K | Hold |
8,496
| – | – | 0.23% | 10 |
|
|
2021
Q3 | $365K | Sell |
8,496
-654
| -7% | -$29K | 0.17% | 11 |
|
|
2021
Q2 | $358K | Hold |
9,150
| – | – | 0.16% | 12 |
|
|
2021
Q1 | $332K | Hold |
9,150
| – | – | 0.16% | 12 |
|
|
2020
Q4 | $337K | Sell |
9,150
-494
| -5% | -$18.1K | 0.17% | 12 |
|
|
2020
Q3 | $336K | Buy |
9,644
+158
| +2% | +$5.54K | 0.21% | 6 |
|
|
2020
Q2 | $294K | Hold |
9,486
| – | – | 0.2% | 6 |
|
|
2020
Q1 | $294K | Hold |
9,486
| – | – | 0.24% | 6 |
|
|
2019
Q4 | $350K | Hold |
9,486
| – | – | 0.22% | 6 |
|
|
2019
Q3 | $390K | Hold |
9,486
| – | – | 0.27% | 6 |
|
|
2019
Q2 | $390K | Hold |
9,486
| – | – | 0.27% | 6 |
|
|
2019
Q1 | $356K | Hold |
9,486
| – | – | 0.24% | 6 |
|
|
2018
Q4 | $393K | Hold |
9,486
| – | – | 0.26% | 6 |
|
|
2018
Q3 | $397K | Hold |
9,486
| – | – | 0.25% | 6 |
|
|
2018
Q2 | $326K | Hold |
9,486
| – | – | 0.22% | 7 |
|
|
2018
Q1 | $319K | Hold |
9,486
| – | – | 0.23% | 6 |
|
|
2017
Q4 | $325K | Hold |
9,486
| – | – | 0.2% | 13 |
|
|
2017
Q3 | $321K | Hold |
9,486
| – | – | 0.19% | 14 |
|
|
2017
Q2 | $302K | Hold |
9,486
| – | – | 0.17% | 15 |
|
|
2017
Q1 | $300K | Hold |
9,486
| – | – | 0.18% | 16 |
|
|
2016
Q4 | $292K | Hold |
9,486
| – | – | 0.22% | 16 |
|
|
2016
Q3 | $305K | Hold |
9,486
| – | – | 0.25% | 16 |
|
|
2016
Q2 | $314K | Sell |
9,486
-3,162
| -25% | -$101K | 0.27% | 15 |
|
|
2016
Q1 | $356K | Hold |
12,648
| – | – | 0.26% | 17 |
|
|
2015
Q4 | $387K | Hold |
12,648
| – | – | 0.26% | 19 |
|
|
2015
Q3 | $377K | Hold |
12,648
| – | – | 0.23% | 23 |
|
|
2015
Q2 | $402K | Hold |
12,648
| – | – | 0.2% | 23 |
|
|
2015
Q1 | $417K | Hold |
12,648
| – | – | 0.18% | 31 |
|
|
2014
Q4 | $374K | Hold |
12,648
| – | – | 0.14% | 34 |
|
|
2014
Q3 | $355K | Hold |
12,648
| – | – | 0.13% | 34 |
|
|
2014
Q2 | $356K | Hold |
12,648
| – | – | 0.13% | 37 |
|
|
2014
Q1 | $385K | Hold |
12,648
| – | – | 0.14% | 34 |
|
|
2013
Q4 | $368K | Hold |
12,648
| – | – | 0.14% | 34 |
|
|
2013
Q3 | $345K | Hold |
12,648
| – | – | 0.14% | 34 |
|
|
2013
Q2 | $336K | Buy |
+12,648
| New | +$349K | 0.14% | 35 |
|
Other funds holding PFE
Cabot-Wellington's PFE Position: Q3 2022 in Review
Cabot-Wellington sold out of Pfizer (PFE) in Q3 2022, closing a stake of 4,832 shares — an estimated $253K sold.
Cabot-Wellington first reported a position in PFE in Q2 2013 and held it in 37 quarters. The position peaked at $502K in Q4 2021. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Cabot-Wellington reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
- Cabot-Wellington sold 4,832 Pfizer shares in Q3 2022, an estimated $253K.
- Cabot-Wellington first reported a position in Pfizer in Q2 2013 and held it in 37 quarters.
- Cabot-Wellington's Pfizer position peaked at $502K in Q4 2021.
- 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Cabot-Wellington's 13F filing for Q3 2022, filed 21 Mar 2023.